Sara D. De Martin-Martin
Padova, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanisms.
Journal: Pharmacological research
Published: October 30, 2025
Tyrosol attenuates NASH features by reprogramming the hepatic immune milieu.
Journal: European journal of pharmacology
Published: August 22, 2023
The phenolic compounds tyrosol and hydroxytyrosol counteract liver fibrogenesis via the transcriptional modulation of NADPH oxidases and oxidative stress-related miRNAs.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 07, 2022
Nemorosone inhibits the proliferation and migration of hepatocellular carcinoma cells.
Journal: Life sciences
Published: July 03, 2019
Dopamine-mediated immunomodulation affects choroid plexus function.
Journal: Brain, behavior, and immunity
Published: January 30, 2019
Pregnane X receptor and constitutive androstane receptor modulate differently CYP3A-mediated metabolism in early- and late-stage cholestasis.
Journal: World journal of gastroenterology
Published: August 04, 2017
The Phytocomplex from Fucus vesiculosus and Ascophyllum nodosum Controls Postprandial Plasma Glucose Levels: An In Vitro and In Vivo Study in a Mouse Model of NASH.
Journal: Marine drugs
Published: October 21, 2016
An intracellular adrenomedullin system reduces IL-6 release via a NF-kB-mediated, cAMP-independent transcriptional mechanism in rat thymic epithelial cells.
Journal: Cytokine
Published: June 30, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026